TIE 2025: MOEA DoIT to Demonstrate AI Innovations with Eye-Catching Tech Waterfall Taking Center Stage

TAIPEI, Oct. 7, 2025 /PRNewswire/ -- The Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs (MOEA) will showcase over 65 innovative technology applications across diverse industries at the Innovation Economy Pavilion during the Taiwan Innotech Expo (TIE), held from October 16 to 18. The event will bring together over 12 research institutes and industry partners under its purview. The most attention-grabbing exhibit is the 3-meter-high technology waterfall, powered by Industrial Technology Research Institute (ITRI)'s Massive Devices Digital Twin Performing Technology. It  simultaneously controls displays and robotic arms, offering new interactive display possibilities for large-scale expositions and art events . Another notable innovation is the AI Recognition Technology for Blended Fiber Multi-Spectral Imaging that identifies the composition of second-hand clothing, paving the way for a circular business model in the textiles industry. This year, TIE also features several biomedical breakthroughs, including the world's first NTSR1-targeted Antibody-Drug Conjugate (ADC) drug, offering new hope for patients with head and neck cancer. Visitors are invited to explore and witness how AI is driving innovations across smart manufacturing, netzero sustainability, and healthcare.

Centered on the theme AI Ecosystem Connecting All Industries, this year's Innovation Economy Pavilion presents five key sectors: Semiconductors, Smart Machinery, Next-Generation Communications, Precision Health, and Energy Transformation, showcasing Taiwan's innovation excellence and industrial dynamism. During textile recycling, conventional manual visual inspection is not only labor-intensive and error-prone, but also incapable of determining the compositional ratios of blended fabrics, leading to misclassification, low-purity reuse, and high disposal rates. Supported by DoIT, the Taiwan Textile Research Institute (TTRI) has developed the AI Recognition Technology for Blended Fiber Multi-Spectral Imaging, integrating near-infrared spectroscopy, biomimetic optical modules, and AI multi-material identification algorithms to achieve a 95% recognition rate. The technology has been validated at a department store and is available for a public hands-on experience.

The showcase also includes innovative research and development outcomes in  biomedicine. Head and neck cancer sees approximately 8,000 new cases per year in Taiwan as incidence rates are significantly higher in Asia. The global head and neck cancer drug market was valued at approximately USD 2.09 billion in 2021, and is projected to grow to USD 4.33 billion by 2026, an annual growth rate of 15.7%. Currently, the main treatments for head and neck cancer include surgery, radiation therapy, and chemotherapy, with limited efficacy and frequent severe side effects. The Development Center for Biotechnology (DCB) and the National Health Research Institutes (NHRI) have developed a novel therapeutic tool for head and neck cancer treatment "NTSR1-ADC" which features high homogeneity and endocytosis efficiency. It targets cancer cells with precision, enhancing drug delivery efficiency while reducing non-specific toxicity to normal cells, thereby improving overall treatment safety and efficacy. Animal studies have confirmed significant tumor growth inhibition effects, and preliminary toxicology studies conducted in non-human primates have also shown no significant toxic reactions. To date, no ADC drugs targeting NTSR1 exist worldwide. Should it reach the market, this will be the world's first NTSR1-targeted ADC drug, enabling Taiwan to capture global market share and strengthen its autonomous ADC development capabilities.

SOURCE Taiwan Innotech Expo